Skip to Main Content

Paper Details

Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study.
Pigment Cell Melanoma Res
8
2022
ARID2, BRAF, BRAF mutant, BRAF mutant tumors, CDKN2A, NF1, NF1 mutant, NF1 mutant tumors, NRAS, Stage II, TERT, TP53, TP53 mutations, Triple Wild Type, Triple Wild Type tumors, cutaneous melanoma, early, early-stage tumors, melanoma, melanomas, microRNAs, nevi, patients, primary cutaneous melanoma, solar elastosis, tumor, tumor infiltrating lymphocytes, tumors
Author NameAffiliation
Ronglai ShenMemorial Sloan Kettering Cancer Center
Arshi AroraMemorial Sloan Kettering Cancer Center
Arshi Arora
Richard A ScolyerMelanoma Institute of Australia, The University of Sydney
Richard A ScolyerThe University of Sydney
Richard A ScolyerRoyal Prince Alfred Hospital and NSW Health Pathology
Richard A ScolyerThe University of Sydney
Sharon N EdmistonDepartment of Dermatology and Lineberger Comprehensive Cancer Center, University of North Carolina
Kathleen ConwayDepartment of Dermatology and Lineberger Comprehensive Cancer Center, University of North Carolina
Marcus BosenbergYale University
  • 1 - 10

Datasets

Release 1.2